Roberto R. Gil, PhD, and Rongchao Jin, PhD, of Carnegie Mellon University of Pittsburgh have used nuclear MR to analyze the structure of infinitesimal gold nanoparticles, which could advance the development and use of the tiny particles in drug development.
As part of a $4.5 million, nine-year effort to employ molecular imaging and nanotechnology in developing “theragnosis”—simultaneous diagnostics and therapeutics—partnering research teams from Purdue University’s Discovery Park and the Korean Institute of Science and Technology will hold a daylong symposium, Sept. 6, in West Lafayette, Ind.
64Cu-bis-DOTA-hypericin has potential to image thermal therapy-induced tumor cell damage, according to a study in this month’s Journal of Nuclear Medicine.
A class of engineered nanoparticles—Raman-silica-gold-nanoparticles—has been shown to be safe when administered by two alternative routes in mouse models, according to a study published April 20 in Science Translational Medicine. This marks the first step up the ladder of toxicology studies that, within a year and a half, could yield to human trials of these agents for detection of colorectal and possibly other cancers.
Eisai’s U.S. subsidiary Morphotek has acquired certain assets relating to a proprietary tumor targeting platform from TransMolecular.
Folate-targeted nanoparticle Paclitaxel Y90 is a biologically-targeted chemoradiotherapy for ovarian cancer and represents a potential novel treatment for ovarian peritoneal metastases, according to a presentation at the annual meeting of the American Association for Cancer Research (AACR) last week in Orlando, Fla.
Researchers have demonstrated that a process using nanotechnology combined with mass spectrometric analysis can assess whether cancer drugs hit their targets, which may help reduce drug side effects, according to a study published online March 31 in Agnewandte Chemie International Edition.
Tiny gold particles can help doctors detect circulating tumor cells in the blood of patients with head and neck cancer and other cancers, according to research published online Feb. 11 in Cancer Research.
RSS 
